Ticker
BCABCompany Name
BIOATLA INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Debt | Shareholders Equity | Invested Capital |
---|---|---|---|
6/30/2025 | $ 6.04M | $ -16.75M | $ -10.7M |
3/31/2025 | $ 554K | $ 547K | $ 1.1M |
12/31/2024 | $ 836K | $ 14.27M | $ 15.1M |
9/30/2024 | $ 1.25M | $ 22.97M | $ 24.22M |
6/30/2024 | $ 1.66M | $ 31.37M | $ 33.03M |
3/31/2024 | $ 1.92M | $ 49.72M | $ 51.64M |
12/31/2023 | $ 2.46M | $ 70.67M | $ 73.13M |
9/30/2023 | $ 2.85M | $ 94.7M | $ 97.55M |
6/30/2023 | $ 3.23M | $ 124.52M | $ 127.75M |
3/31/2023 | $ 3.61M | $ 156.43M | $ 160.03M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Debt + Equity
(=) Inv. Capital
Inv. Capital for BIOATLA INC is calculated as follows: Debt [ $ 682K ] + Equity [ $ -74.52M ]
(=) Inv. Capital [ $ -73.84M ]
Minimum
Sep 30, 2020
Maximum
Sep 30, 2021
Average
Median
filtered constituents | 3.44K |
---|---|
min | $ -1.51B |
max | $ 4.11B |
average | $ 760.7M |
median | $ 303.53M |
std | $ 1B |